Table 1 Comparison of clinicopathological characteristics between the subtotal gastrectomy and total gastrectomy groups
Variable | Subtotal gastrectomy | Total gastrectomy | P value |
|---|---|---|---|
(n = 21) (%) | (n = 24) (%) | ||
Age (years) | 62.9 ± 7.8 | 63.5 ± 8.5 | 0.720 |
Sex | Â | Â | 0.670 |
 Male | 19 (90.5) | 20 (83.3) |  |
 Female | 2 (9.5) | 4 (16.7) |  |
BMI | 21.2 ± 2.8 | 21.0 ± 3.4 | 0.885 |
ASA status | Â | Â | Â |
 I–II | 14 (66.7) | 16 (66.7) | 1.000 |
 III | 7 (33.3) | 8 (33.3) |  |
Comorbidity | Â | Â | Â |
 Any | 5 (23.8) | 2 (8.3) | 0.255 |
 Diabetes | 1 (4.8) | 0 |  |
 Cardiac | 0 | 1 (4.2) |  |
 Hypertension | 4 (19.0) | 1 (4.2) |  |
Previous reconstruction | Â | Â | 1.000 |
 Billroth I | 1 (4.8) | 1 (4.2) |  |
 Billroth II | 20 (95.2) | 23 (95.8) |  |
Time interval (year, mean) | 32.4 ± 7.4 | 31.7 ± 9.9 | 0.788 |
Histology type | Â | Â | 0.376 |
 Differentiated | 12 (57.1) | 10 (41.7) |  |
 Undifferentiated | 9 (42.9) | 14 (58.3) |  |
Tumor location | Â | Â | 0.193 |
 Anastomotic site | 20 (95.2) | 19 (78.2) |  |
 Gastric body | 1(4.8) | 5 (20.8) |  |
Tumor size (cm) | 4.0 ± 1.4 | 5.2 ± 2.5 | 0.072 |
pT stage | Â | Â | 0.830 |
 T1a/1b | 2 (9.5) | 2 (8.3) |  |
 T2 | 4 (19.0) | 2 (8.3) |  |
 T3 | 2 (9.5) | 2 (8.3) |  |
 T4a/4b | 13 (61.9) | 18 (75.0) |  |
pN stage | Â | Â | 0.360 |
 N0 | 13 (61.9) | 9 (37.5) |  |
 N1 | 4 (19.0) | 5 (20.8) |  |
 N2 | 2 (9.5) | 5 (20.8) |  |
 N3 | 2 (9.5) | 5 (20.8) |  |
TNM stage | Â | Â | 0.346 |
 I | 4 (19.0) | 4 (16.7) |  |
 II | 8 (38.1) | 5 (20.8) |  |
 III | 9 (42.9) | 15 (62.5) |  |
Borrmann type | Â | Â | 0.692 |
 I | 10 (41.7) | 10 (41.7) |  |
 II | 5 (23.8) | 3 (12.5) |  |
 III | 2 (9.5) | 5 (20.8) |  |
 IV | 2 (9.5) | 4 (16.7) |  |
 Early stage | 2 (9.5) | 2 (8.3) |  |
Adjuvant chemotherapy | Â | Â | 0.807 |
 Yes | 12 (57.1) | 14 (58.3) |  |
 No | 7 (33.3) | 9 (37.5) |  |
 Missing | 2 (9.5) | 1 (4.2) |  |